Difference between revisions of "Yamashina T, et al. Cancer Res. (2014) cited as Ref 463 in DOI: 10.1038/s41392-020-0110-5 (Q9726)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 74, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English) | ||
| Property / title: Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:02, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yamashina T, et al. Cancer Res. (2014) cited as Ref 463 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yamashina T
0 references
2014
0 references
Cancer Res.
0 references
74
0 references
Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English)
0 references
